RGC - Regencell Corp Forvard narx/daromad multiplikatori
Xitoy tabibligi dori vositalari uchun qat'iy sertifikatsiya talablari Regencell Bioscience (RGC) uchun kirishning sezilarli to'siqlarini yaratadi. Forward P/S tendentsiyasi joriy baholashni aks ettiradi, bunda parametr belgisi ga tengdir. Biroq, Big Pharma bilan ittifoqlarning yo'qligi o'sishni cheklaydi, klinik sinovlar bosqichi va nol savdo hajmi esa doimiy yo'qotishlarga hamda tashqi moliyalashtirishga bog'liqlikka olib keladi.
RGC (Regencell Corp): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi statistikasi:
- biznesning balans baholash tafsilotlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Regencell Bioscience|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Regencell Bioscience|RGC - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar Regencell Corp|RGC - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Regencell Bioscience|Tezkor likvidlik koeffitsiyenti regencellbioscience.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
RGC - Kompaniyaning sof daromadi|Kutilayotgan foyda Regencell Bioscience|RGC - Narx-foyda multiplikatori|Forvard P/E multiplikatori Regencell|RGC - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Regencell Corp|RGC - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Regencell Bioscience|RGC - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi regencellbioscience.com|RGC - Joriy yilda bir aksiya uchun sof foydaning o'zgarishi|Keyingi yil uchun foyda o'sishi prognozi Regencell Bioscience
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Regencell Bioscience Holdings Limited RGC
Regencell Bioscience (RGC) uchun, uning ishlanmalari bozor narxini belgilash imkoniyatiga ega bo'lmagan dastlabki bosqichlarda bo'lgani sababli, forward P/S ko'rsatkichi kelgusidagi savdolarga oid spekulyativ kutishlarning o'lchovi bo'lib xizmat qiladi. Forward P/S dagi o'zgarishlarni tahlil qilish orqali investor tebranishlardan tozalangan joriy bozor kapitalizatsiyasining prognoz qilingan daromadga nisbatini kuzatishi mumkin, bu esa kompaniyaning dori vositalari tijoratga chiqarilishidan oldin uning baholashini tahlil qilish uchun juda muhimdir.
Regencell Bioscience (RGC) raqobatchilari
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|Neurocrine - Narxning prognoz qilingan daromadga nisbati|AXSM: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ACAD (ACADIA Corp)|XENE: Forvard P/S multiplikatori|VKTX (vikingtherapeutics.com) - Narxning prognoz qilingan daromadga nisbati|SUPN (Supernus) - Forvard P/S multiplikatori|Catalyst Pharma (CPRX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Denali Therapeutics Inc (DNLI)|HRMY - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Biohaven Ltd. BHVN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati amylyx.com (AMLX)|Trevi Therapeutics, Inc. - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Forvard narx/daromad multiplikatori|AVXL: Forvard P/S multiplikatori|CBLL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|PRTA (Prothena Biosciences) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alector Therapeutics ALEC|Narxning prognoz qilingan daromadga nisbati Annexon (ANNX)|omeros.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Corp)|ACIU - Forvard narx/daromad multiplikatori|Voyager Therapeutics - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati neumoratx.com|Scilex (SCLX) - Narxning prognoz qilingan daromadga nisbati|Tevogen Bio Holdings Inc. - Sotuvga nisbatan forvard narx|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|CGTX - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori IKT|Forvard narx/daromad multiplikatori cassavasciences.com SAVA|Narxning prognoz qilingan daromadga nisbati Assertio ASRT|COYA: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|VistaGen Therapeutics Inc - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Ovid Therapeutics Inc.|ABOS (Acumen Pharmaceuticals) - Forvard narx/daromad multiplikatori|cervomed.com (CRVO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Ltd.|CLNN: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|JUNS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics RLMD|Sotuvga nisbatan forvard narx ANVS|Grace Tx - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Firefly Neuroscience, Inc.|KLTO: Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati NeuroSense Therapeutics Ltd. NRSN|RVPH (Reviva Pharmaceuticals) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati MetaVia, Inc. MTVA|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|heliusmedical.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori PASG (Passage Bio)|NEUP - Forvard narx/daromad multiplikatori|Minerva Neurosciences - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati athira.com|Addex Therapeutics Ltd (ADXN) - Narxning prognoz qilingan daromadga nisbati|ALZN (Alzamend Neuro) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Cyclerion Therapeutics Inc.|Narxning prognoz qilingan daromadga nisbati PTIX|Forvard narx/daromad multiplikatori KTTA (Pasithea Therapeutics)|CRGT (cortigent.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|Brainstorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics, Inc - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Chromocell CHRO|eliemtx.com (ELYM) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|Narxning prognoz qilingan daromadga nisbati Longboard Pharmaceuticals, Inc.|Marinus Pharmaceuticals Inc (MRNS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori NKGN|Forvard narx/daromad multiplikatori NeuroBo Pharma NRBO|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati synaptogen.com (SNPX)|Trevena - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vigil Neuroscience|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati CERE
